FTC Files Contempt Motion Against Amare Global and Three Individuals Over Unsubstantiated Health Claims
FTC files contempt motion against Amare Global for unsubstantiated health claims, signaling heightened enforcement against deceptive marketing in the supplement industry.
Aforeworn detected this change in the Dietary-Supplement Labeling (FDA) space on July 7, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Supplement brands, contract manufacturers, private-label sellers, ingredient suppliers should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediately; ongoing compliance needed to avoid enforcement actions.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Dietary-Supplement Labeling (FDA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
FTC is seeking contempt sanctions for continued unsubstantiated claims after a prior order, indicating zero tolerance for non-compliance.
Who it affects
Supplement brands, contract manufacturers, private-label sellers, ingredient suppliers
What you must do
Review all marketing claims for substantiation; ensure no disease treatment claims without FDA approval; verify structure/function claims have competent and reliable scientific evidence.
Deadline
Immediately; ongoing compliance needed to avoid enforcement actions.
Never miss a change like this again
Aforeworn watches Dietary-Supplement Labeling (FDA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Dietary-Supplement Labeling (FDA)
- FTC Sends Warning Letters to Companies About Compliance with the TAKE IT DOWN Act
- FTC Sues to Stop Amare Global Holdings from Misrepresenting the Health Benefits of Its Dietary Supplements for Children and Adults
- FTC Issues Report to Congress on Adoption Practices
- FTC Warns Companies Making Questionable ‘Made in the USA’ Claims
- FDA Expands Sunscreen Options for the First Time in 20 Years